Find Nonprofit and Small Business Grants

Advance Search

Only Available for Paid Subscribers
Clear Filters
Search Filters

Grant to a USA or Canada and Israel Collaborative Partnership to Research Pediatric Cancer

Pediatric Sarcomas


GrantWatch ID#

Funding Source
Samuel Waxman Cancer Research Foundation (SWCRF) and Alan B. Slifka Foundation (ABSF)
Array ( )

Geographic Focus

Important Dates
LOI Date: 06/01/23
Deadline: 08/31/23 5:00 PM EDT Save

Grant Description
Grant to a USA or Canada and Israel collaborative partnership for research related to pediatric cancer. Applicants are required to submit an LOI prior to a full grant application. Funding is intended for a partnership between a North American and an Israeli research team for research to understand, prevent, or treat pediatric sarcomas with an emphasis on Ewing sarcoma.

The Samuel Waxman Cancer Research Foundation (SWCRF), Alan B. Slifka Foundation (ABSF) and Israel Cancer Research Fund (ICRF) are pleased to issue a joint Request for Applications (RFA) for collaborative applications focused on fusion-positive pediatric sarcomas. Projects must involve collaboration between two research groups — one in North America and one in Israel — with different but complementary expertise. Proposals must justify the partnership through synergistic scientific aims.

Proposals will be prioritized for funding based on their potential to contribute to understanding, preventing and effectively treating pediatric sarcomas, with an emphasis on Ewing sarcoma. Appropriate research topics will include, but are not limited to:

  • Metastatic disease and how to prevent or treat metastasis
  • Relapsed disease and how to prevent metastasis
  • The Ewing oncoprotein EWS/FLI and its roles in tumor development
  • Discovery of new pathways, targets and biomarkers for diagnosis and treatment
  • Development of improved technologies for delivery of therapies to tumor cells

Recipients of these awards are encouraged to develop collaborations that extend beyond the original team and terms of the grant and form a community of investigators committed to:

  • Collaboration
    • Sharing of research materials, reagents and/or core resources
    • Joint publications
    • Development of program project grants (P01s) and/or collaborative R01s
    • Development of new research projects that enhance other programs funded by SWCRF, ABSF and ICRF.
  • Communication
    • Presentation at the annual Connective Tissue Oncology Society (CTOS) meeting
    • Interactions at the annual SWCRF Scientific Review Meeting 


Additional Eligibility Criteria
Projects must involve a collaborative partnership formed by two research groups, one in North America and one in Israel. Each group must be represented by a Principal Investigator (PI) responsible for the research proposed and carried out by that group.

To encourage applications from highly-qualified Israeli investigators, applications for this program will be accepted from investigators simultaneously applying for other specific categories of ICRF grants (Professorships, Project Grants, Acceleration Grants), and from investigators currently funded by specific categories of ICRF grants (Project Grants, Acceleration Grants, Career Development Awards). However, investigators may not hold two different ICRF grants at the same time, and successful applicants with other ICRF funding will be required to forfeit that other funding when this new funding initiates.

Pre-Application Information
- Submit LOI by: June 1, 2023, 5 pm EDT
- Invitations for Full Application by: July 1, 2023
- Full application due by: Aug 31, 2023, 5 pm EDT
- Funding decision by: Nov 30, 2023
- Funding begins Jan 1, 2024

Number of Grants

Estimated Size of Grant
One successful collaborative project will be awarded $150,000 per year for two years, or a total of $300,000, with each university-based research group receiving $75,000 per year ($150,000 total).

Term of Contract
2 years

Contact Information
Submit LOIs to:

Questions? Email Wylie Tene (; Ellen Rubin
(; or Allison Sole (

Israel Cancer Research Fund
52 Vanderbilt Avenue, Suite 1510
New York, New York 10017-3834

Phone: 212-969-9800
Toll Free: 888-654-ICRF (4273)
Fax: 212-969-9822

Grant News
Live Chat Chat Now